Navigation Links
Injection Helps Treat Hard-to-Control Type 2 Diabetes
Date:4/23/2010

Adding daily shot improves blood glucose levels when standard regimen fails, study finds

FRIDAY, April 23 (HealthDay News) -- Patients with type 2 diabetes who can't control their blood glucose levels with the drug metformin alone do better after adding injections of the drug liraglutide compared to oral doses of another drug called sitagliptin, researchers report.

In the study, Dr. Richard E. Pratley, of the University of Vermont College of Medicine in Burlington, and his colleagues randomly assigned patients whose blood glucose wasn't sufficiently controlled by metformin (Glucophage) to receive 26 weeks of treatment with liraglutide (Victoza) by injection or sitagliptin (Januvia) by mouth.

The researchers found that the patients did better on liraglutide, although between 21 percent and 27 percent of patients reported nausea, compared to 5 percent of those on sitagliptin, according to the report published in the April 24 issue of The Lancet.

Liraglutide "was well-tolerated with minimum risk of hypoglycemia. These findings support the use of liraglutide as an effective agent to add to metformin," they wrote in a news release from the journal.

In a commentary accompanying the study, Dr. Andre J. Scheen and Dr. Regis P. Radermecker of the University of Liege in Belgium noted that patients may think it's easier to take one sitagliptin pill a day compared to daily injections of liraglutide. And liraglutide, they added, is more expensive, but it has improved benefits in terms of blood glucose control and weight reduction.

More information

For more about type 2 diabetes, visit the American Diabetes Association.



-- Randy Dotinga



SOURCE: The Lancet, news release, April 22, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Issues Warning on Fat-Melting Spa Injections
2. A Study by Celibre Medical Corporation Shows Botox Injections to be the Most Desirable Cosmetic Procedure in Southern California
3. Injections May Boost Knee Surgery Success
4. For Achilles Overuse, Plasma Injections Look No Better Than Placebo
5. Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly
6. Injections Arent Solution for Retained Placenta: Study
7. Allegheny Medical's Occupational Health Services Helps Employers Build a Healthier Workforce
8. Epione Helps Women Get Ready for Bikini Season without Hitting the Gym
9. Latest Resource From Dynamic Disc Designs Helps Physicians Educate Patients
10. No Evidence That Lithium Helps in ALS
11. Cost-Effective Program Helps Prevent Repeat Teen Births
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... BSI and Brenntag Canada have been appointed ... for distribution of their natural fruits and beverage colorants effective November 1, ... addition to our Life Sciences product portfolio,” said Steve Brauer, President of Brenntag Specialties, ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Point Partners ("GPP") portfolio company, today announced it has acquired the assets ... TCS was previously a subsidiary of Chiltern International and focuses on clinical ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-Aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research ... Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease ... - Global Forecasts to 2021" report to their offering. ... , , ... USD 730.7 Million in 2021 from USD 574.8 Million in 2016, ...
(Date:12/5/2016)...   BIOTRONIK today announced the first patients ... the safety and feasibility of performing the minimally invasive ... BioMonitor 2 is an insertable cardiac remote monitor ... a patient,s skin to help physicians accurately detect and ... a leading cause of stroke and heart failure. BioMonitor ...
(Date:12/5/2016)... Dec. 5, 2016  CVS Health, the nation,s largest ... a perfect score of 100 percent on the Corporate ... CEI is an annual national benchmarking survey and report ... administered by the Human Rights Campaign Foundation. ... that our colleagues, customers and suppliers bring to CVS ...
Breaking Medicine Technology: